NEW YORK (GenomeWeb News) — Molecular Devices today said fourth-quarter revenues remained virtually flat as R&D spending was unchanged and profit decreased 31 percent.
Total receipts for the three months ended Dec. 31, 2006, increased to $52.8 million from $52.7 million year over year.
Molecular Devices did not break out revenues by business unit.
R&D spending was flat at $6.3 million in both quarters.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.